Bioinformatic	B:C1140694
analysis	B:C0936012
of	O
RNA	B:C0162327
-	I:C0162327
seq	I:C0162327
data	O
unveiled	O
critical	B:C0017337
genes	I:C0017337
in	O
rectal	B:C0149978
adenocarcinoma	I:C0149978
.	O

RNA	B:C0162327
-	I:C0162327
seq	I:C0162327
data	O
of	O
rectal	B:C0149978
adenocarcinoma	I:C0149978
(	O
rectal	B:C0149978
adenocarcinoma	I:C0149978
)	O
were	O
analyzed	B:C0936012
with	O
bioinformatics	B:C1140694
tools	I:C1140694
to	O
unveil	B:C0005516
potential	I:C0005516
biomarkers	I:C0005516
in	O
the	O
disease	B:C0012634
.	O

RNA	B:C0162327
-	I:C0162327
seq	I:C0162327
data	O
of	O
rectal	B:C0149978
adenocarcinoma	I:C0149978
were	O
downloaded	O
from	O
The	B:C3273927
Cancer	I:C3273927
Genome	I:C3273927
Atlas	I:C3273927
(	O
The	B:C3273927
Cancer	I:C3273927
Genome	I:C3273927
Atlas	I:C3273927
)	O
database	B:C0242356
.	O

Differential	O
analysis	B:C0936012
was	O
performed	O
with	O
package	B:C0282574
edgeR	I:C0282574
.	O

False	O
discovery	O
rate	O
(	O
FDR	O
)	O
<	O
0.05	O
and	O
|log2	O
(	O
fold	O
change	O
)	O
|>	O
1	O
were	O
set	O
as	O
cut	O
-	O
off	O
values	O
to	O
screen	O
out	O
differentially	B:C0017337
expressed	I:C0017337
genes	I:C0017337
(	O
differentially	B:C0017337
expressed	I:C0017337
genes	I:C0017337
)	O
.	O

Gene	B:C0017262
coexpression	I:C0017262
network	B:C1720950
was	O
constructed	O
with	O
package	B:C0282574
Ebcoexpress	I:C0282574
.	O

Gene	B:C1138831
Ontology	I:C1138831
enrichment	O
analysis	B:C0936012
was	O
performed	O
for	O
the	O
differentially	B:C0017337
expressed	I:C0017337
genes	I:C0017337
in	O
the	O
gene	B:C0017262
coexpression	I:C0017262
network	O
with	O
DAVID	B:C0029038
online	I:C0029038
tool	I:C0029038
.	O

Kyoto	B:C0014095
Encyclopedia	I:C0014095
of	O
Genes	B:C0017337
and	O
Genomes	B:C0017428
pathway	O
enrichment	O
analysis	B:C0936012
was	O
also	O
performed	O
for	O
the	O
genes	B:C0017337
with	O
KOBASS	B:C0029038
2.0	O
.	O

A	O
total	O
of	O
620	O
differentially	B:C0017337
expressed	I:C0017337
genes	I:C0017337
,	O
3ated	O
genes	B:C0017337
,	O
and	O
231	O
down	B:C0013081
-	I:C0013081
regulated	I:C0013081
genes	B:C0017337
,	O
were	O
identified	O
from	O
163	O
rectal	B:C0149978
adenocarcinoma	I:C0149978
samples	O
and	O
9	O
normal	O
controls	O
.	O

A	O
gene	B:C0017262
coexpression	I:C0017262
network	O
consisting	O
of	O
71	O
differentially	B:C0017337
expressed	I:C0017337
genes	I:C0017337
and	O
253	O
edges	O
were	O
constructed	O
.	O

Genes	B:C0017337
were	O
associated	O
with	O
ribosome	B:C0035553
and	O
focal	B:C0887870
adhesion	I:C0887870
functions	O
.	O

Three	O
modules	B:C1959595
were	O
identified	O
,	O
in	O
which	O
genes	B:C0017337
were	O
involved	O
in	O
muscle	B:C0026820
contraction	I:C0026820
,	O
negative	B:C2610375
regulation	I:C2610375
of	I:C2610375
glial	I:C2610375
cell	I:C2610375
proliferation	I:C2610375
and	O
extracellular	B:C1160609
matrix	I:C1160609
organization	I:C1160609
functions	O
,	O
respectively	O
.	O

Several	O
critical	O
hub	B:C0017337
genes	I:C0017337
were	O
disclosed	O
,	O
such	O
as	O
RPS2	B:C1419718
,	O
MMP1	B:C1417199
,	O
MMP11	B:C1366519
and	O
FAM83H	B:C1825168
.	O

Thirteen	O
relevant	O
small	B:C1254351
molecule	I:C1254351
drugs	I:C1254351
were	O
identified	O
,	O
such	O
as	O
scriptaid	B:C0917681
and	O
spaglumic	B:C2348231
acid	I:C2348231
.	O

A	O
total	O
of	O
8	O
TFs	B:C0040648
and	O
5	B:C1101610
miRNAs	I:C1101610
were	O
acquired	O
,	O
such	O
as	O
MYC	B:C0086661
,	O
NFY	B:C0910920
,	O
STAT5A	B:C1335875
,	O
miR	B:C2605694
-	I:C2605694
29	I:C2605694
,	O
miR-200	B:C2713655
and	O
miR-19	B:C2933761
.	O

Several	O
critical	O
genes	B:C0017337
and	O
relevant	O
drugs	B:C3687832
,	O
TFs	B:C0040648
and	O
miRNAs	B:C1101610
were	O
revealed	O
in	O
rectal	B:C0149978
adenocarcinoma	I:C0149978
.	O

These	O
findings	O
could	O
advance	O
the	O
understanding	O
about	O
the	O
disease	B:C0012634
and	O
benefit	O
therapy	O
development	O
.	O

